Related Experiment Videos
Déjà vu for breast cancer two?
Journal of the National Cancer Institute
|April 8, 2004
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Impact of Tamoxifen Only After Lumpectomy for "Good-Risk" Duct Carcinoma In Situ: Combined Analysis of the NRG Oncology/RTOG 9804 and ECOG-ACRIN E5194 Trials.
International journal of radiation oncology, biology, physics·2026
Estrogen receptor-positive cell line xenograft models recapitulate metastatic dissemination and endocrine response of invasive lobular breast carcinoma.
bioRxiv : the preprint server for biology·2026
Endocrine therapy in early-stage estrogen Receptor-Low breast cancer: a systematic review and Meta-Analysis.
Journal of the National Cancer Institute·2026
Development and validation of a predictive model of aromatase inhibitor-induced arthralgia among patients with early breast cancer.
Journal of the National Cancer Institute·2026
Leiomyosarcoma survival across anatomical sites identifies high- and low-risk patient groups to inform clinical trial design.
Journal of the National Cancer Institute·2026
Redefining reach: inclusivity gaps in UK phase 3 head and neck trial protocols over the last decade.
Journal of the National Cancer Institute·2026
Prospective multicenter validation of a Urine-Based multiplex assay for risk stratification of patients presenting with gross hematuria.
Journal of the National Cancer Institute·2026
Cervical human papillomavirus status among women with chronic inflammatory rheumatic diseases: matched cohort study.
Journal of the National Cancer Institute·2026
Renal Cell Carcinoma Texture Analysis With the KiTS23 Dataset: A Retrospective Study.
Advances in urology·2026